ArticleJournal of hepatocellular carcinoma2023

Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.

Teng Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.